{
  "id": 5466,
  "text": "Available at: http://www.ncbi.nlm.nih.gov/pubmed/21147905.284.Beriwal S, Gan GN, Heron DE, et al.Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Available at: http://www.ncbi.nlm.nih.gov/pubmed/21147905.284.Beriwal S, Gan GN, Heron DE, et al.Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "基于现有的研究，结合同步化疗和扩展区域适形调强放疗（IMRT）在宫颈癌的治疗中显示出一定的临床效果。同步化疗通过增强放疗的敏感性，可以提高肿瘤细胞的杀伤效果。而扩展区域的IMRT在靶向治疗宫颈癌的同时，能够更精确地减少邻近正常组织的辐射剂量，从而降低副作用风险。\n\n早期的临床结果表明，这种治疗方式对宫颈癌患者的局部控制率和无病生存率表现出积极的作用，尤其是在病情较为复杂，如有盆腔或淋巴结区域扩散风险的患者中。然而，仍需注意治疗的毒性管理，特别是对胃肠道和泌尿系统的不良反应。\n\n因此，这种联合治疗模式在患者选择和疗程设计上需进行个体化评估，以最大化疗效并降低风险。",
  "query": "有关宫颈癌的早期临床结果与同步化疗及扩大区域的适形调强放疗的结合使用有哪些？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 有关宫颈癌的早期临床结果与同步化疗及扩大区域的适形调强放疗的结合使用有哪些？\n\n<reference text>: Available at: http://www.ncbi.nlm.nih.gov/pubmed/21147905.284.Beriwal S, Gan GN, Heron DE, et al.Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "基于现有的研究，结合同步化疗和扩展区域适形调强放疗（IMRT）在宫颈癌的治疗中显示出一定的临床效果。同步化疗通过增强放疗的敏感性，可以提高肿瘤细胞的杀伤效果。而扩展区域的IMRT在靶向治疗宫颈癌的同时，能够更精确地减少邻近正常组织的辐射剂量，从而降低副作用风险。\n\n早期的临床结果表明，这种治疗方式对宫颈癌患者的局部控制率和无病生存率表现出积极的作用，尤其是在病情较为复杂，如有盆腔或淋巴结区域扩散风险的患者中。然而，仍需注意治疗的毒性管理，特别是对胃肠道和泌尿系统的不良反应。\n\n因此，这种联合治疗模式在患者选择和疗程设计上需进行个体化评估，以最大化疗效并降低风险。"
}